Zenas BioPharma, Inc.
USD17.13
-1.04 (-5.72%)
CEO
Leon Oliver Moulder Jr.
IPO Date
2024-09-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$17.78
Prev. Close
$18.17
Day Low
$16.90
Day High
$18.11
52W Low
$8.91
52W High
$44.60
Market Cap
$0.76B
Volume
0.57M
| 25,000 |
| $18.02 |
| 29 Apr 2026 | MOULDER LEON O JR | director, officer: Chief Executive Officer | P-Purchase | Acquired | 35,000 | $17.62 |
| 2 Apr 2026 | Lu Hongbo | director | P-Purchase | Acquired | 3,768 | $18.63 |
| 1 Apr 2026 | Fairmount Funds Management LLC | director | P-Purchase | Acquired | 150,000 | $20.00 |
| 31 Mar 2026 | MOULDER LEON O JR | director, officer: Chief Executive Officer | P-Purchase | Acquired | 20,000 | $18.23 |
| 31 Mar 2026 | MOULDER LEON O JR | director, officer: Chief Executive Officer | P-Purchase | Acquired | 34,000 | $19.31 |
| 31 Mar 2026 | Lu Hongbo | director | P-Purchase | Acquired | 75,000 | $20.00 |
| 13 Feb 2026 | Lu Hongbo | director | P-Purchase | Acquired | 25,985 | $22.50 |
| 13 Feb 2026 | Allen Patricia L | director | P-Purchase | Acquired | 5,000 | $26.50 |